ZGOO Holdings KRX:221800KOSDAQ
유투바이오 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked0since Sep 11
In Q2 2026, ZGOO Holdings reported revenue of ₩12.0bn, up 76.0% year on year, and an operating loss of ₩549m. ZGOO Holdings (유투바이오) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Filing signals 4 quarters of losses Screener
ZGOO Holdings quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩12.0bn | +76.0% | −₩549m margin −4.6% | −₩3.9bn |
| Q1 2026 | ₩7.0bn | +24.2% | −₩1.6bn margin −22.8% | −₩398m |
| Q4 2025 derived | ₩6.3bn | +0.1% | −₩857m margin −13.7% | −₩679m |
| Q3 2025 | ₩6.9bn | +6.8% | −₩586m margin −8.5% | −₩746m |
| Q2 2025 | ₩6.8bn | +1.0% | −₩205m margin −3.0% | ₩31m |
| Q1 2025 | ₩5.6bn | +0.7% | −₩710m margin −12.6% | −₩249m |
| Q4 2024 derived | ₩6.3bn | -16.5% | −₩1.2bn margin −18.5% | −₩2.0bn |
| Q3 2024 | ₩6.4bn | +0.4% | −₩812m margin −12.6% | −₩450m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
ZGOO Holdings top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest ZGOO Holdings news Korean headlines
No articles yet.